|
市場調査レポート
商品コード
1729294
日本の遺伝子治療市場レポート：遺伝子タイプ、ベクタータイプ、デリバリー方法、用途、地域別、2025年～2033年Japan Gene Therapy Market Report by Gene Type, Vector Type, Delivery Method, Application, and Region 2025-2033 |
||||||
カスタマイズ可能
|
|||||||
| 日本の遺伝子治療市場レポート：遺伝子タイプ、ベクタータイプ、デリバリー方法、用途、地域別、2025年～2033年 |
|
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 119 Pages
納期: 5～7営業日
|
- 全表示
- 概要
- 目次
日本の遺伝子治療の市場規模は2024年に3億4,300万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに11億3,320万米ドルに達し、2025年から2033年にかけて14.2%の成長率（CAGR）を示すと予測しています。遺伝性疾患の有病率の上昇、遺伝子編集技術の最近の動向、日本政府による支援政策の実施、研究開発（R&D）への投資の増加は、市場を牽引する主な要因の一部です。
本レポートで扱う主な質問
- 日本の遺伝子治療市場はこれまでどのように推移し、今後どのように推移するのか？
- COVID-19が日本の遺伝子治療市場に与えた影響は？
- 日本の遺伝子治療市場の遺伝子タイプ別区分は？
- 日本の遺伝子治療市場のベクタータイプ別の区分は？
- 日本の遺伝子治療市場のデリバリー方法別の内訳は？
- 日本の遺伝子治療市場の用途別区分は？
- 日本の遺伝子治療市場のバリューチェーンにおける様々なステージとは？
- 日本の遺伝子治療市場の主な促進要因と課題は何か？
- 日本の遺伝子治療市場の構造と主要プレーヤーは？
- 日本の遺伝子治療市場における競合の程度は？
目次
第1章 序文
第2章 調査範囲と調査手法
- 調査の目的
- ステークホルダー
- データソース
- 市場推定
- 調査手法
第3章 エグゼクティブサマリー
第4章 日本の遺伝子治療市場：イントロダクション
- 概要
- 市場力学
- 業界動向
- 競合情報
第5章 日本の遺伝子治療市場情勢
- 過去および現在の市場動向（2019～2024年）
- 市場予測（2025～2033年）
第6章 日本の遺伝子治療市場：遺伝子タイプ別の内訳
- 抗原
- サイトカイン
- 腫瘍抑制剤
- 自殺遺伝子
- 欠乏
- 成長因子
- 受容体
- その他
第7章 日本の遺伝子治療市場：ベクタータイプ別の内訳
- ウイルスベクター
- 非ウイルス技術
第8章 日本の遺伝子治療市場：デリバリー方法別の内訳
- In-Vivo遺伝子治療
- Ex-Vivo遺伝子治療
第9章 日本の遺伝子治療市場：用途別の内訳
- 腫瘍性疾患
- 希少疾患
- 心血管疾患
- 神経疾患
- 感染症
- その他
第10章 日本の遺伝子治療市場：競合情勢
- 概要
- 市場構造
- 市場企業のポジショニング
- 主要成功戦略
- 競合ダッシュボード
- 企業評価象限
第11章 主要企業のプロファイル
第12章 日本の遺伝子治療市場：業界分析
- 促進要因、抑制要因、機会
- ポーターのファイブフォース分析
- バリューチェーン分析
第13章 付録
The Japan gene therapy size reached USD 343.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,133.2 Million by 2033, exhibiting a growth rate (CAGR) of 14.2% during 2025-2033. The escalating prevalence of genetic disorders, recent advancements in gene editing technologies, implementation of supportive policies by the Government of Japan, and the increasing investment in research and development (R&D) represent some of the key factors driving the market.
Gene therapy is a groundbreaking approach in the medical field, designed to address and potentially eradicate diseases through the modification of genes within an individual's cells. This advanced technique encompasses the introduction, deletion, or alteration of genetic material in a patient's cells, with the primary aim of rectifying the genetic anomalies causing various diseases. The essential components of gene therapy include therapeutic deoxyribonucleic acid (DNA), a delivery vector that facilitates the transfer of DNA into cells, and sophisticated gene-editing technologies, such as CRISPR. It finds application across numerous domains, including cancer treatment, management of viral infections, tackling cardiovascular diseases (CVDs), neurological disorders, autoimmune diseases, age-related illnesses, specific types of blindness, and genetic disorders, including hemophilia, cystic fibrosis, and sickle cell disease.
Japan Gene Therapy Market Trends:
The escalating prevalence of genetic disorders and cancers in Japan, which has prompted the need for innovative treatment methods, such as gene therapy, is propelling the market growth. Additionally, the recent advancements in gene editing technologies such as CRISPR/Cas9, which have improved the accuracy of gene modifications and enhanced the success rates of therapies, are contributing to the market growth. Furthermore, the substantial investments in research and development (R&D) activities by pharmaceutical and biotech companies to develop effective and innovative gene therapies are boosting the market growth. Along with this, the implementation of supportive regulations and policies by the Government of Japan to accelerate approval processes and promote gene therapy trials and products is stimulating the market growth. Besides this, the emergence of advanced vector delivery systems, which improve gene therapy's efficacy and minimize potential side effects, thus ensuring more effective and safer treatment options, is supporting the market growth. Moreover, the heightened awareness about gene therapy and its potential benefits among healthcare professionals and patients is strengthening the market growth. Apart from this, the growing strategic alliances and collaborations among universities, research institutions, and companies to boost innovation and broaden the potential for commercialization are catalyzing the market growth. In addition, the escalating geriatric population, which is highly susceptible to various age-related diseases, such as Parkinson's disease, osteoarthritis, Alzheimer's disease, and age-related macular degeneration (AMD), is fueling the market growth. Other factors, including rising healthcare expenditure, growing adoption of precision medicines, and increasing demand for innovative therapies, are anticipated to drive the market growth.
Japan Gene Therapy Market Segmentation:
Gene Type Insights:
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide Gene
- Deficiency
- Growth Factors
- Receptors
- Others
Vector Type Insights:
- Viral Vector
- Adenoviruses
- Lentiviruses
- Retroviruses
- Adeno-Associated Virus
- Herpes Simplex Virus
- Poxvirus
- Vaccinia Virus
- Others
- Non-Viral Techniques
- Naked and Plasmid Vectors
- Gene Gun
- Electroporation
- Lipofection
- Others
Delivery Method Insights:
- In-Vivo Gene Therapy
- Ex-Vivo Gene Therapy
Application Insights:
- Oncological Disorders
- Rare diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- Others
Competitive Landscape:
- The report has also provided a comprehensive analysis of the competitive landscape in the Japan gene therapy market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan gene therapy market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan gene therapy market?
- What is the breakup of the Japan gene therapy market on the basis of gene type?
- What is the breakup of the Japan gene therapy market on the basis of vector type?
- What is the breakup of the Japan gene therapy market on the basis of delivery method?
- What is the breakup of the Japan gene therapy market on the basis of application?
- What are the various stages in the value chain of the Japan gene therapy market?
- What are the key driving factors and challenges in the Japan gene therapy market?
- What is the structure of the Japan gene therapy market and who are the key players?
- What is the degree of competition in the Japan gene therapy market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan Gene Therapy Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan Gene Therapy Market Landscape
- 5.1 Historical and Current Market Trends (2019-2024)
- 5.2 Market Forecast (2025-2033)
6 Japan Gene Therapy Market - Breakup by Gene Type
- 6.1 Antigen
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
- 6.2 Cytokine
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
- 6.3 Tumor Suppressor
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
- 6.4 Suicide Gene
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
- 6.5 Deficiency
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2019-2024)
- 6.5.3 Market Forecast (2025-2033)
- 6.6 Growth Factors
- 6.6.1 Overview
- 6.6.2 Historical and Current Market Trends (2019-2024)
- 6.6.3 Market Forecast (2025-2033)
- 6.7 Receptors
- 6.7.1 Overview
- 6.7.2 Historical and Current Market Trends (2019-2024)
- 6.7.3 Market Forecast (2025-2033)
- 6.8 Others
- 6.8.1 Overview
- 6.8.2 Historical and Current Market Trends (2019-2024)
- 6.8.3 Market Forecast (2025-2033)
7 Japan Gene Therapy Market - Breakup by Vector Type
- 7.1 Viral Vector
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Segmentation
- 7.1.3.1 Adenoviruses
- 7.1.3.2 Lentiviruses
- 7.1.3.3 Retroviruses
- 7.1.3.4 Adeno-Associated Virus
- 7.1.3.5 Herpes Simplex Virus
- 7.1.3.6 Poxvirus
- 7.1.3.7 Vaccinia Virus
- 7.1.3.8 Others
- 7.1.4 Market Forecast (2025-2033)
- 7.2 Non-Viral Techniques
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Segmentation
- 7.2.3.1 Naked and Plasmid Vectors
- 7.2.3.2 Gene Gun
- 7.2.3.3 Electroporation
- 7.2.3.4 Lipofection
- 7.2.3.5 Others
- 7.2.4 Market Forecast (2025-2033)
8 Japan Gene Therapy Market - Breakup by Delivery Method
- 8.1 In-Vivo Gene Therapy
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
- 8.2 Ex-Vivo Gene Therapy
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
9 Japan Gene Therapy Market - Breakup by Application
- 9.1 Oncological Disorders
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
- 9.2 Rare Diseases
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
- 9.3 Cardiovascular Diseases
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
- 9.4 Neurological Disorders
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2019-2024)
- 9.4.3 Market Forecast (2025-2033)
- 9.5 Infectious Disease
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2019-2024)
- 9.5.3 Market Forecast (2025-2033)
- 9.6 Others
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2019-2024)
- 9.6.3 Market Forecast (2025-2033)
10 Japan Gene Therapy Market - Competitive Landscape
- 10.1 Overview
- 10.2 Market Structure
- 10.3 Market Player Positioning
- 10.4 Top Winning Strategies
- 10.5 Competitive Dashboard
- 10.6 Company Evaluation Quadrant
11 Profiles of Key Players
- 11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Services Offered
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
- 11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Services Offered
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
- 11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Services Offered
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
- 11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Services Offered
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
- 11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Services Offered
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events
12 Japan Gene Therapy Market - Industry Analysis
- 12.1 Drivers, Restraints and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
- 12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
- 12.3 Value Chain Analysis
